Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ani Pharmaceuticals (ANIP) Net Income: 2010-2024

Historic Net Income for Ani Pharmaceuticals (ANIP) over the last 15 years, with Dec 2024 value amounting to -$18.5 million.

  • Ani Pharmaceuticals' Net Income rose 210.07% to $26.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.5 million, marking a year-over-year increase of 671.57%. This contributed to the annual value of -$18.5 million for FY2024, which is 198.63% down from last year.
  • Latest data reveals that Ani Pharmaceuticals reported Net Income of -$18.5 million as of FY2024, which was down 198.63% from $18.8 million recorded in FY2023.
  • Over the past 5 years, Ani Pharmaceuticals' Net Income peaked at $18.8 million during FY2023, and registered a low of -$47.9 million during FY2022.
  • For the 3-year period, Ani Pharmaceuticals' Net Income averaged around -$15.9 million, with its median value being -$18.5 million (2024).
  • Per our database at Business Quant, Ani Pharmaceuticals' Net Income plummeted by 1,076.09% in 2020 and then soared by 139.21% in 2023.
  • Over the past 5 years, Ani Pharmaceuticals' Net Income (Yearly) stood at -$35.8 million in 2020, then dropped by 19.16% to -$42.6 million in 2021, then dropped by 12.42% to -$47.9 million in 2022, then skyrocketed by 139.21% to $18.8 million in 2023, then crashed by 198.63% to -$18.5 million in 2024.